AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Intaglip-M SR 500 Tablet

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Intaglip-M SR 500 Tablet

Metformin and glimepiride extended-release tablets (500mg) manage elevated blood glucose in type 2 diabetes patients. This dual-action therapy mitigates severe diabetic complications like nephropathy and vision impairment, potentially lowering cardiovascular event risk. Prescribed independently or adjunctively with other antidiabetic agents, optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Ingestion with meals minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar regulation helps prevent future complications. Maintaining your prescribed diet and exercise regimen is crucial for diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported adverse effects include diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; therefore, recognizing and treating hypoglycemia is essential. This medication isn't universally suitable. Prior to initiating treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic dysfunction, or significant alcohol consumption. Consult your doctor before use if pregnant or breastfeeding. Inform your doctor of all medications you're currently taking to ensure medication compatibility and safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout therapy.

Primary Ingredients of Intaglip-M SR 500 Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Intaglip-M SR 500 Tablet

Managing Type 2 diabetes

Major Benefits of Intaglip-M SR 500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Intaglip-M SR 500 Tablets should be administered with a meal.

Common Side effects of Intaglip-M SR 500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Intaglip-M SR 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Intaglip-M SR 500 Tablet with a meal.

How Intaglip-M SR 500 Tablet works:

Metformin and glimepiride extended-release tablets (500mg) offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Intaglip-M SR 500 Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Intaglip-M SR 500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Sustained-release Intaglip-M 500 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

For individuals with impaired kidney function, the use of Intaglip-M SR 500 Tablets requires careful monitoring. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Use of Intaglip-M SR 500 Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Intaglip-M SR 500 Tablet :

Should you forget to take a dose of Intaglip-M SR 500 Tablet, administer it immediately if feasible. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Intaglip-M SR 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Intaglip-M SR 500 Tablet

Intaglip-M SR 500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may occur, especially if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Intaglip-M SR 500 Tablets may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Intaglip-M SR 500 Tablets are contraindicated in patients with allergies to any ingredient. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Intaglip-M SR 500 Tablet combines metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Intaglip-M SR 500 Tablet can cause lactic acidosis, a serious, though rare, medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Intaglip-M SR 500 Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Intaglip-M SR 500 Tablet is safe when used as directed by your doctor. However, even with proper dosage, common side effects may include nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially if combined with insulin or sulfonylurea). Report any persistent issues to your doctor.
Intaglip-M SR 500 Tablet
76
MRP 88
13% off